Changes in CIPN severity
CIPN
CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, ADVERSE EVENT
At baseline, 92.3% (48/52) of patients had grade 2 CIPN (Fig. Numbers of patients with change in grade of chemotherapy-induced peripheral neuropathy according to the Common Terminology Criteria for Adverse Events over 12 weeks (full analysis set). Data are presented as percentage of patients. Changes in FACT/GOG-NTX and Modified TNSr total scores for the FAS and PPS are summarized in Supplementary Table 